BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stejskal D, Karpísek M, Humenanska V, Hanulova Z, Stejskal P, Kusnierova P, Petzel M. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res 2008;40:381-5. [PMID: 18393169 DOI: 10.1055/s-2008-1062746] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Makris K, Stefani D, Makri E, Panagou I, Lagiou M, Sarli A, Lelekis M, Kroupis C. Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: Analytical performance and establishment of reference values. Clin Biochem 2015;48:1291-7. [PMID: 26297118 DOI: 10.1016/j.clinbiochem.2015.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
2 Stepan H, Philipp A, Reiche M, Klostermann K, Schrey S, Reisenbüchler C, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M. Serum levels of the adipokine lipocalin-2 are increased in preeclampsia. J Endocrinol Invest 2010;33:629-32. [DOI: 10.1007/bf03346661] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
3 Schmid M, Dalela D, Tahbaz R, Langetepe J, Randazzo M, Dahlem R, Fisch M, Trinh QD, Chun FKH. Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery. World J Nephrol 2015; 4(2): 160-168 [PMID: 25949930 DOI: 10.5527/wjn.v4.i2.160] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
4 Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505-17. [PMID: 22962216 DOI: 10.1515/cclm-2011-0814] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
5 Sivalingam Z, Larsen SB, Grove EL, Hvas AM, Kristensen SD, Magnusson NE. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease. Clin Chem Lab Med 2017;56:5-18. [PMID: 28672731 DOI: 10.1515/cclm-2017-0120] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
6 Dertli R, Biyik M, Yolacan R, Karakarcayildiz A, Keskin M, Kayar Y, Asil M. May Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Predict Mortality in Patients with Hepatocellular Carcinoma (HCC)? J Gastrointest Cancer 2020;51:932-8. [PMID: 31729643 DOI: 10.1007/s12029-019-00323-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 El-hadidi H, Samir N, Shaker OG, Otb S. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome. Arch Dermatol Res 2014;306:239-45. [DOI: 10.1007/s00403-013-1414-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
8 Borkham-Kamphorst E, van de Leur E, Zimmermann HW, Karlmark KR, Tihaa L, Haas U, Tacke F, Berger T, Mak TW, Weiskirchen R. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. Biochim Biophys Acta. 2013;1832:660-673. [PMID: 23376114 DOI: 10.1016/j.bbadis.2013.01.014] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 8.8] [Reference Citation Analysis]
9 Robberecht H, Hermans N. Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance. Metab Syndr Relat Disord 2016;14:47-93. [PMID: 26808223 DOI: 10.1089/met.2015.0113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
10 Yun BA, Yang EM, Kim CJ. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Renal Parenchymal Involvement in Infants With Febrile Urinary Tract Infection: A Preliminary Study. Ann Lab Med 2018;38:425-30. [PMID: 29797812 DOI: 10.3343/alm.2018.38.5.425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Żyłka A, Dumnicka P, Kuśnierz-Cabala B, Gala-Błądzińska A, Ceranowicz P, Kucharz J, Ząbek-Adamska A, Maziarz B, Drożdż R, Kuźniewski M. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Mediators Inflamm 2018;2018:7659243. [PMID: 30158836 DOI: 10.1155/2018/7659243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
12 Martin RA, Ather JL, Daggett R, Hoyt L, Alcorn JF, Suratt BT, Weiss DJ, Lundblad LK, Poynter ME. The endogenous Th17 response in NO2-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from Th17 adoptive transfer. PLoS One 2013;8:e74730. [PMID: 24069338 DOI: 10.1371/journal.pone.0074730] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
13 Auguet T, Quintero Y, Terra X, Martínez S, Lucas A, Pellitero S, Aguilar C, Hernández M, del Castillo D, Richart C. Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity (Silver Spring) 2011;19:2295-300. [PMID: 21455126 DOI: 10.1038/oby.2011.61] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
14 Cruz DN, Virzì GM, Brocca A, Ronco C, Giavarina D. A comparison of three commercial platforms for urinary NGAL in critically ill adults. Clin Chem Lab Med 2016;54:353-62. [PMID: 26087067 DOI: 10.1515/cclm-2015-0464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Corripio R, Gónzalez-clemente J, Pérez-sánchez J, Näf S, Gallart L, Nosàs R, Vendrell J, Caixàs A. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study. European Journal of Endocrinology 2010;163:887-93. [DOI: 10.1530/eje-10-0408] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
16 Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm. 2010;2010:513948. [PMID: 20508843 DOI: 10.1155/2010/513948] [Cited by in Crossref: 132] [Cited by in F6Publishing: 142] [Article Influence: 12.0] [Reference Citation Analysis]
17 Verma M, Dahiya K, Soni A, Dhankhar R, Ghalaut VS, Bansal A, Kaushal V. Levels of neutrophil gelatinase-assosciated lipocalin in patients with head and neck squamous cell carcinoma in Indian population from Haryana state. World J Clin Oncol 2017; 8(3): 261-265 [PMID: 28638796 DOI: 10.5306/wjco.v8.i3.261] [Reference Citation Analysis]
18 Rashad NM, El-Shal AS, Etewa RL, Wadea FM. Lipocalin-2 expression and serum levels as early predictors of type 2 diabetes mellitus in obese women. IUBMB Life 2017;69:88-97. [PMID: 28116808 DOI: 10.1002/iub.1594] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
19 Ong K, Tso AWK, Cherny SS, Sham P, Lam T, Lam KSL, Cheung BMY; on behalf of the Investigators of the Hong Kong Cardiovascular Risk Factor Prevalence Study. Role of Genetic Variants in the Gene Encoding Lipocalin-2 in the Development of Elevated Blood Pressure. Clinical and Experimental Hypertension 2011;33:484-91. [DOI: 10.3109/10641963.2010.549276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Solak Y, Yilmaz MI, Siriopol D, Saglam M, Unal HU, Yaman H, Gok M, Cetinkaya H, Gaipov A, Eyileten T, Sari S, Yildirim AO, Tonbul HZ, Turk S, Covic A, Kanbay M. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2015;47:1993-2001. [PMID: 26498629 DOI: 10.1007/s11255-015-1136-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ataseven A, Kesli R, Kurtipek GS, Ozturk P. Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis. Dis Markers 2014;2014:541709. [PMID: 24803721 DOI: 10.1155/2014/541709] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
22 Meyer S, van der Meer P, van Deursen VM, Jaarsma T, van Veldhuisen DJ, van der Wal MHL, Hillege HL, Voors AA. Neurohormonal and clinical sex differences in heart failure. European Heart Journal 2013;34:2538-47. [DOI: 10.1093/eurheartj/eht152] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
23 Baran A, Świderska M, Myśliwiec H, Flisiak I. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels. J Dermatolog Treat 2017;28:136-40. [PMID: 27165470 DOI: 10.1080/09546634.2016.1180340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
24 Kamata M, Tada Y, Tatsuta A, Kawashima T, Shibata S, Mitsui H, Asano Y, Sugaya M, Kadono T, Kanda N, Watanabe S, Sato S. Serum lipocalin-2 levels are increased in patients with psoriasis: Lipocalin-2 levels are increased in psoriasis. Clinical and Experimental Dermatology 2012;37:296-9. [DOI: 10.1111/j.1365-2230.2011.04265.x] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
25 Matet A, Jaworski T, Bousquet E, Canonica J, Gobeaux C, Daruich A, Zhao M, Zola M, Meester-Smoor M, Mohabati D, Jaisser F, Yzer S, Behar-Cohen F. Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy. Sci Rep 2020;10:20175. [PMID: 33214636 DOI: 10.1038/s41598-020-77202-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Currò D, Vergani E, Bruno C, Comi S, D'Abate C, Mancini A. Plasmatic lipocalin-2 levels in chronic low-grade inflammation syndromes: Comparison between metabolic syndrome, total and partial adult growth hormone deficiency. Biofactors 2020;46:629-36. [PMID: 32196782 DOI: 10.1002/biof.1628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 Meier EM, Pohl R, Rein-fischboeck L, Schacherer D, Eisinger K, Wiest R, Krautbauer S, Buechler C. Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis. Cytokine 2016;85:45-50. [DOI: 10.1016/j.cyto.2016.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
28 Tsigou E, Psallida V, Demponeras C, Boutzouka E, Baltopoulos G. Role of new biomarkers: functional and structural damage. Crit Care Res Pract. 2013;2013:361078. [PMID: 23476755 DOI: 10.1155/2013/361078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
29 Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring) 2010;18:890-6. [PMID: 19834460 DOI: 10.1038/oby.2009.335] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]